Patent ID: 11905284
Assignee: PFIZER INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 0:
1. A method of treating an M4-associated disease or disorder comprising administering a compound to a subject in need thereof, wherein the compound is selected from:
1-(2,4-Dimethyl-5,7-dihydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-2-{1-[2-(trifluoromethyl)pyridin-4-yl]azetidin-3-yl}ethanone and
1-[2-(hydroxymethyl)-4-methyl-5,7-dihydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-2-{1-[2-(trifluoromethyl)pyridin-4-yl]azetidin-3-yl}ethanone,
or an N-oxide thereof, or a pharmaceutically acceptable salt of the compound or the N-oxide,
wherein the M4-associated disease or disorder is selected from the group consisting of schizophrenia, psychosis, and cocaine and alcohol dependence and abuse.